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Summary 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 
infections (ALRI) in children. This is the first study using original source high-quality 
surveillance data to establish a global, robust and homogeneous report on global 
country-specific RSV seasonality. 
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ABSTRACT 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 
infections (ALRI) in children. By the age of 1 year, 60–70% of children have been 
infected by RSV. In addition, early-life RSV infection is associated with the 
development of recurrent wheezing and asthma in infancy and childhood. The need 
for precise epidemiologic data regarding RSV as a worldwide pathogen has been 
growing steadily as novel RSV therapeutics are reaching the final stages of 
development. To optimize the prevention, diagnosis and treatment of RSV infection in 
a timely manner, knowledge about the differences in the timing of the RSV epidemics 
worldwide is needed. Previous analyses, based on literature reviews of individual 
reports obtained from medical databases, have fail to provide global country 
seasonality patterns. Until recently, only certain countries have been recording RSV 
incidence through their own surveillance systems. This analysis was based on national 
RSV surveillance reports and medical databases from 27 countries worldwide. This is 
the first study using original source high-quality surveillance data to establish a global, 
robust and homogeneous report on global country-specific RSV seasonality.  
 
Keywords: RSV; RSV Seasonality; RSV Epidemiology; RSV Epidemics; Acute Lower 
Respiratory Infections; Respiratory Infections; RSV Surveillance; Surveillance. 
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BACKGROUND 
 
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory 
infections (ALRI) in children. By the age of 1 year, 60–70% of children have been 
infected by RSV (2–3% of whom are hospitalized), and almost all children have been 
infected by 2 years of age [1]. This virus is estimated to cause approximately 33.8 
million new episodes of ALRI annually in children <5 years of age worldwide, resulting 
in 3.2 million hospital admissions and 59,600 in-hospital deaths in children <5 years in 
2015 [2]. In addition early-life RSV infection is associated with the development of 
recurrent wheezing and asthma in infancy and childhood [3] 
The need for precise epidemiologic data regarding RSV as a worldwide pathogen has 
been growing steadily as novel vaccines and molecules for the prevention and 
treatment of RSV infections are reaching the final stages of development [4]. In order 
to establish timely counter-measures to control the pathogen, information about the 
different epidemic waves of the virus is needed [4]. Many western countries have 
included detection of RSV as part of their influenza surveillance system, especially 
since it was noted that its circulation generally predates that of the influenza virus by 
six to eight weeks. Nevertheless, many countries have not implemented a routine 
surveillance system for RSV, or they have done so only in certain regions, or even 
restricted to specific medical facilities. The aim of this report is to provide an overview 
of RSV seasonality throughout 27 countries across the world. 
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METHODS 
We surveyed 27 countries distributed among nine predefined geographical areas for 
epidemiological data (Figure 1). 
 
Figure 1 
 
Selection strategy 
Selection of the regions studied was done through a two-searches approximation 
conducted between June 2016 to September 2017. A first general search was 
conducted in Google to detect countries with official surveillance programs producing 
accessible reports containing information on RSV seasonality. Terms included were 
“RSV” or “Respiratory syncytial virus” or “Influenza” plus “Surveillance”. A total of 19 
countries were selected. Most surveillance systems had RSV-specific data available 
from laboratory detections, but for France we used syndromic “bronchiolitis” data. To 
complement and compare the information obtained from the official reports and to 
increase the information gathered in poorly covered areas, a literature review was 
performed in PubMed of articles published between 1990 and 2017. Keywords 
included ‘respiratory virus’, OR ‘respiratory syncytial virus,’ OR ‘RSV,’ in combination 
with ‘seasonality’ OR ‘surveillance’. Only studies reflecting specific information on RSV 
seasonality (i.e. start, end, peak or duration of the RSV season) were extracted. A total 
of 8 new countries were added to the initial survey to increase the total number of 
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countries studied to the final figure of 27.  Only records written in English, Spanish, 
German, French and Portuguese were included in this study. 
 
Information retrieved 
Variables recovered from the different reports were as follow: Start and end of the 
RSV season (in epidemiological week or month if the specific week was not available), 
peak of RSV activity (in epidemiological week or month if the specific week was not 
available), duration of the seasons, presence of official RSV surveillance program, 
period studied, region variability and usage of laboratory detection. Data for each 
country were collected by two independent investigators from the ReSVinet 
(Respiratory Syncytial Virus Network) / GENVIP (Genetics, Vaccines, Infectious Diseases 
and Pediatrics) research groups. 
We relied on data provided by official national reports to establish the start and end of 
the RSV season, whenever available. In Europe, the first reports with official data 
about RSV detection are available as early as 1995 for Finland, 1996 for Germany and 
1998 for Belgium, and as late as the end of the 2000s for as Spain and UK. In South and 
Central America, the earliest reports are found in 2009 for Brazil and Argentina. North 
America RSV official seasonality reports date as early as 1983. With the exception of 
New Zealand, that presents information regarding RSV since 1997, the rest of the 
countries studied have accessible data on RSV surveillance starting from the late 
2000s. We recovered information from official surveillance organization reports from 
2010 onwards whenever possible.  
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In countries with no official sources on RSV epidemiology and disease burden, 
information was systematically extracted from the best reliable medical source at our 
disposal. Initially, WHO and CDC reports for each of the countries were reviewed, then 
local and multicenter publications assessing several consecutive RSV seasons were also 
reviewed, and finally a review of published articles documenting RSV burden limited to 
a local area or a group of hospitals were used, if no better sources were available. For 
those countries with no precise information regarding exact timing and duration of 
RSV season, the onset of RSV season was defined as the first two consecutive weeks 
when 10% or higher of the total tested samples for respiratory pathogens were 
positive for RSV. The end of the RSV season was defined similarly when the proportion 
of positive RSV tests fell below 10% for two consecutive weeks. 
 
RESULTS 
Although there were major differences among the 27 countries studied, seasonal RSV 
epidemics within each individual country were consistent over time. We found that 
even when global trends were documented and usually repeated over seasons, some 
variations between different years were observed. Even when most countries included 
(19 out of 27) had official surveillance systems, information devoted to RSV was usually 
scarce and embedded within influenza surveillance reports (Figure 2). Almost every 
sentinel program detected RSV through laboratory methods (excluding France), but 
almost no information regarding the specifics of the microbiological test used was 
available in the majority of the reports.   
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Table 1 and Figure 2 summarize the RSV seasonality data per country, and a detailed 
version of Europe is presented in Figure 3. 
 
Table 1 
 
Figure 2 
 
Figure 3 
 
Globally, RSV epidemics started in the South moving to the North. We found that the 
RSV wave started in most countries situated in the Southern Hemisphere between 
March and June, and in the Northern Hemisphere between September and December 
[5–7]. Decrease in RSV activity was observed from August to October in the Southern 
Hemisphere and from February to May in the Northern Hemisphere [5-7]. Regarding 
duration, most countries in both hemispheres had seasons that occupied from 5 to 6 
months in total. While this was the general rule, shorter seasons were seen in Spain 
(from 3 to 5 months) [8], UK (from 3 to 4 months) [9] and Israel (4 months) [10] in the 
northern hemisphere whilst in the southern hemisphere RSV activity in Australia [11] 
mainly lasts approximately 4 months long. An exception to this patterns was seen in 
countries were humid or rainy seasons was seen,  particularly those near the 
equatorial area like Mozambique [12,13] or Malaysia [14], were RSV tended to linger 
longer, up to 10 months duration.  
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The seasonality was fairly consistent within most regions, although we observed 
variations from year to year. These variations were independent of the hemisphere 
and the majority remained between 1 to 3 weeks difference from season to season in 
the start, end and/or peak of RSV activity. Most countries showed major variations of 1 
month least once during the studied periods. Curiously, these major variations were 
less appreciated in the regions were no surveillance system was stablished (probably 
related to the scarce sources of information found). Despite the straight forward 
trends described, there were some countries that presented irregular patterns. In 
Germany [15], two differential patterns of RSV seasonality have been detected: an 
early season starting in October-November and finishing in March-April and a late 
season starting in December and finishing in May, having both seasons a similar 
duration. RSV infections in Finland, according to the data gathered from the literature 
review, follow a two-year cycle [16,17]. A small epidemic in spring of every odd-
numbered year, is followed by a major epidemic that starts in November-December 
and extends to the next spring. Seasonality also follows a distinctive pattern in Mexico 
[18]. A two-season year is followed by a milder year were the outbreak starts in spring, 
maintaining activity almost all year round with no clear peaks. Intra-country 
differences in seasonality were noted, especially in countries with large territories and 
different regional climatic regions, such as Brazil [19], the USA [20] or Australia [21-23]. 
Additional details and references on seasonality of RSV by region is available in the 
supplemental material. 
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To our knowledge, this is the first study using original source high-quality data relying 
predominantly on the official information gathered by the different surveillance 
networks to establish a global report on country-specific RSV seasonality that allowed 
us to observe the typical worldwide distribution of RSV seasonality at a glance. We 
have included a wide selection of information retrieved not only from research studies, 
but also and more importantly, from the actual surveillance systems in the different 
countries. This method allowed us to obtain better distribution and homogeneity of 
the information acquired than did studies based exclusively on literature reviews. 
Those earlier studies usually recorded information in hospital settings, reporting data 
from few regions or centres, thus failing to establish global country seasonality 
patterns. Furthermore, we could not find in the literature any other review that 
reflects the specific ranges in which seasons and RSV peaks of activity vary during the 
periods studied. Many other original papers are based on regional or single country 
data, and they have been useful for analysing the circulation of RSV in their respective 
regions [6,12-14,16-17,19,22-24,27-48].  
The first global RSV seasonality study found in the literature was conducted in 2002 by 
Stensballe et al. [5]. The authors reported different patterns for the Northern and 
Southern hemispheres and the equatorial region in a city-based format, relying on 
information provided by medical databases. Haynes et al. [6] worked in conjunction 
with the Centers for Disease Control and Prevention (CDC) Global Disease Detection 
Centers to investigate different trends in low- and middle-income countries. They 
analysed the data in conjunction with the climate patterns. The largest study in the 
literature was carried out by Bloom-Feshbach et al. [7] where information from 137 
DISCUSSION 
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global locations based on a literature review, electronic sources and the WHO 
surveillance system FluNet was reported. Their study showed seasonal patterns of RSV 
similar to the present study, with temperate locations of the Northern and Southern 
Hemispheres characterized by focused peaks of activity during their respective winters, 
and a wide range of variability in the timing and duration of epidemics in the tropics.   
In regard to weather conditions, the general rule in temperate climate regions such as 
those of Europe or North America, is that RSV activity follows the decrease in 
temperature. Exceptions were observed  in equatorial countries and tropical areas 
with high humidity, such as the Philippines or Mozambique, where viral circulation is 
seen primarily during the rainy season, although showing residual activity throughout 
the year [5–7]. 
This study is meant to serve as a general guide for RSV seasonality, not only to provide 
general knowledge about the epidemiology of the virus but also to serve as a basis for 
actual preventive and therapeutic strategies against RSV using established prophylaxis 
measures and/or those about to be released to the market. Even though we have 
highlighted the consistency between seasons and  we expect this information to be 
very useful, it should be considered as a complement for the actual information 
gathered in real time by the current surveillance systems. Major variations of a month 
or more that could make a preventive measure useless do occur occasionaly. 
Therefore, we propose that the best approach to predict RSV outbreaks is to construct 
a robust, homogeneous, active and global surveillance program with real-time data to 
help predict the epidemiologic waves in a timely fashion. A number of countries have 
been recording RSV cases through their own surveillance systems for some years now. 
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These countries, however, are part of a minority, and most of them only include RSV 
surveillance as a secondary detection along with other surveillance campaigns (i.e. 
influenza virus and bronchiolitis surveillance), with scarce information regarding RSV. 
In areas without official surveillance systems, one has to rely on single or multicenter 
studies done by various research groups.  
To this respect, the WHO through the Global Influenza Surveillance and Response 
System (GISRS) is in process of implementing a pilot of RSV surveillance based on the 
influenza surveillance platform, with 14 countries selected covering for each of the 
WHO regions [49]. 
Our approach also allowed us to study the seasonality of RSV for longer periods of 
time, as RSV surveillance systems have been in operation in some of the areas for 
many years.  
Prevention of the RSV infection  could not only protect children from the acute effects 
of the disease but also improve long-term respiratory morbidity such as recurrent 
wheezing and asthma [50].  
A limitation of our approach is that information collected from middle- and low-
income countries is scarce as most of these regions lack RSV surveillance networks. In 
particular, we acknowledge that certain regions such as Africa are underrepresented in 
our analysis. As the main approach of this review is describing the seasonality of RSV, 
we did not analyze further epidemiological data like transmission patterns or activity 
of other viral pathogens. Although the effect of climate in the different RSV seasonality 
patterns was observed in the study for different countries, we did not conduct a deep 
analysis of this fact, as actual meteorological data was not extracted during the review. 
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It will be interesting to further develop this idea in following analyses. Although most 
of the surveillance programs do perform sample testing in subjects with symptoms of 
respiratory infection, those surveillance networks were influenza like illness is the 
driver of sampling performance could underestimate RSV epidemic unless Influenza 
and RSV overlap. Finally, circulation of the different RSV subtypes was not further 
analyzed, as almost no surveillance network differentiates between the different 
genotypes. We decided not to include information in this respect as the literature is 
based on small sample studies carried out for short periods, preventing a global review 
of the subject.   
 
In summary, this report provides information that may allow prediction of the 
beginning of outbreaks of RSV across the world. Even when local epidemic waves are 
consistent between different years, minor changes between seasons are present from 
year to year. This variability could turn a prophylactic measure into a useless endeavor 
if, for example, vaccination campaigns against RSV begin when the outbreak has 
already started. Therefore, as the data has shown, future seasonal RSV vaccinations 
campaigns should be organized after the different patterns repeated in each region 
where the program is planned to be implemented. Although a general dissemination 
pattern exists for RSV, the described variations from season to season justify 
introduction of new well-organized supranational and country- or region-based RSV-
specific surveillance tools to predict these variations, as it has been done for Influenza 
virus infections in the past. The experience with the Influenza virus model has taught 
us that the effectiveness of efforts directed towards preventive and prophylactic 
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measures would be increased if the seasonal and epidemiological characteristics of the 
virus waves could be better predicted.  As novel RSV therapeutics are expected to soon 
become available [20], local seasonality data will allow optimizing the prevention, 
diagnosis and treatment of RSV infections.  
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Table 1.  
Country 
Start 
(season week) 
Peak 
(season 
week) 
End 
(season 
week) 
Season 
length 
(weeks) 
Period 
studied 
Region 
variability 
EUROPE 
Belgium 39-43 49-50 7-13 18-22 2004-2014 No 
France 
(official, 
syndromic-
based) 
35-37 48-52 10-14 25-31 2011-2017 No 
France 
(Unofficial 
RSV 
surveillance) 
October-November December 
February-
March 
20-24 2011-2014 No data 
Finland 50-1 7-10 17-20 19-21 2010-2015 Yes 
Germany 
Early 40-47 52 11-15 19-21 
2010-2017 No 
Late 50-52 52-16 18 16-22 
Greece December February Apr/May 20 1999-2013 No data 
Italy October Jan/Feb April/May 24-30 2000-2014 Yes 
The 
Netherlands 
45-49 51-8 15-17 19-23 2010-2016 No data 
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Spain 44-45 50-52 6-12 12-19 2010-2017 No 
United 
Kingdom 
43-45 49-52 4-6 11-15 2010-2016 No 
AMERICA 
North America 
Canada 46-49 52-8 15-18 20-22 2012-2017 Yes 
USA 44-46 52-4 12-14 21-23 2011-2017 Yes 
Central America 
Guatemala 16-23 30-34 43-47 25-31 2015-2017 No 
Mexico 
1 
35-39 
17-18 
37-45 
17-20 
46-47 
17-20 
7-12 2012-2015 No data 
13-16 20-30 29-42 16-36 
South America 
Argentina 16-19 24-27 35-40 20-22 2011-2017 No 
Brazil 7-11 14-19 29-31 19-24 
2009- 
2017 
Yes 
Chile 19-22 26-32 36-41 16-20 
2011- 
2017 
Yes 
SOUTHERN AFRICA 
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Mozambique October March May 16-40 1998-2000 No data 
South Africa 2-9 10-18 19-33 19-33 2009-2016 No 
OCEANIA 
Australia 19-23 27-31 34-38 14-16 
2009- 
2016 
Yes 
New Zealand 18-20 29-34 35-39 19-23 
2010- 
2015 
No 
ASIA 
Middle East 
Israel 44-49 51-3 5-9 13-18 2005-2017 No 
Southern Asia 
Malaysia July Sep-Dec March 36 1982-2008 No 
Philippines October Nov-Dec February 20 2010-2013 Yes 
Thailand April-May September November 24 2005-2011 No 
East Asia 
China November Dec-Feb April 24 2010-2015 Yes 
Japan 30-45 41-50 45-9 14-27 2010-2017 No Data 
South Korea Aug-Oct 
Mid Oct-
Nov 
December 14-20 2008-2016 No Data 
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Footnote: Summary of seasonality data organized by region and country. Numbers show the range of epidemiological weeks 
or months (depending on available data). 
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